来源：新浪证券-红岸工作室 融资方面，港通医疗当日融资买入183.27万元。当前融资余额3002.12万元，占流通市值的1.94%，融资 余额低于近一年10%分位水平，处于低位。 融券方面，港通医疗12月1日融券偿还0.00股，融券卖出0.00股，按当日收盘价计算，卖出金额0.00元； 融券余量100.00股，融券余额2218.00元，超过近一年90%分位水平，处于高位。 资料显示，四川港通医疗设备集团股份有限公司位于四川省成都市简阳市凯力威工业大道南段356号， 成立日期1998年1月13日，上市日期2023年7月25日，公司主营业务涉及为医疗机构提供以医用气体系统 及医院洁净手术部为核心的医疗专业工程整体方案。主营业务收入构成为：医用洁净装备及系统 55.69%，医用气体装备及系统37.30%，医疗设备及其他产品销售4.06%，运维服务2.81%，其他(补 充)0.14%。 截至11月20日，港通医疗股东户数7895.00，较上期减少2.64%；人均流通股7984股，较上期增加 2.71%。2025年1月-9月，港通医疗实现营业收入3.44亿元，同比减少30.06%；归母净利润-1020.84万 元，同比 ...

Core Viewpoint - The Central Financial Work Conference prioritizes technology finance, emphasizing the role of financial services in empowering technological innovation, with Hangyin Wealth Management being a pioneer in supporting tech innovation through innovative financial products and services [1][2]. Group 1: Company Initiatives - Hangyin Wealth Management has been involved in technology equity investment since 2015, creating the "Jinzuan Venture Capital" series of products, and has provided direct equity financing to over 1,400 tech startups, accumulating an investment scale exceeding 37 billion yuan by June 2025 [1][2]. - The company has established a three-dimensional service system focusing on product innovation, full-process management, and professional capability to effectively connect financial resources with tech enterprises [2][3]. Group 2: Investment Strategies - The company launched the "Jinzuan Venture Capital" private wealth management products to efficiently channel idle social funds into supporting unlisted tech companies, addressing critical gaps in the financing chain for tech enterprises [2][3]. - Hangyin Wealth Management has developed a comprehensive "fundraising-investment-management-exit" process management mechanism, leveraging a decade of experience in tech equity investment [2][3]. Group 3: Sector-Specific Achievements - In the healthcare sector, the company invested 160 million yuan in BJPC Medical Equipment Co., which has developed a brain pacemaker that breaks foreign monopolies in the domestic market [3]. - In the aerospace sector, the company has supported leading enterprises like BJTB Technology Co. and Beijing HTYX Technology Co. through collaborative investments [3]. Group 4: Competitive Advantages - Hangyin Wealth Management benefits from its location in the economically vibrant Yangtze River Delta, where local governments prioritize the development of tech enterprises [4]. - The company leverages the mature ecosystem of its parent bank, Hangzhou Bank, which has over ten years of experience in technology finance, providing unique advantages in industry knowledge and client resources [4]. Group 5: Challenges and Recommendations - Despite its advantages, the company faces challenges in product issuance, performance reference, fund matching, and investment capabilities due to the relatively short history of the industry [5]. - Recommendations for enhancing the capability of wealth management firms in supporting tech innovation include strengthening research capabilities, adapting to the long investment cycles of tech enterprises, and fostering a collaborative industry environment [5][6][7][8].

Market Performance - The Hang Seng Index closed at 26,033, up 0.67% for the day and up 29.78% year-to-date [1] - The Hang Seng Tech Index rose by 0.82% to 5,644, with a year-to-date increase of 26.33% [1] - The Shanghai Composite Index increased by 0.65% to 3,914, with a year-to-date rise of 16.77% [1] - The Dow Jones Index fell by 0.90% to 47,289, with a year-to-date increase of 11.15% [1] Currency and Commodity Overview - The Renminbi Index stands at 97.920, with a 1-month increase of 0.38% and a 6-month increase of 1.79% [2] - Brent crude oil is priced at $63.570 per barrel, down 0.98% over the past month but up 3.13% over the past six months [2] - Gold is priced at $4,256.22 per ounce, with a 1-month increase of 6.37% and a 6-month increase of 25.87% [2] Company News - Kangji Medical's privatization plan has been approved by the Grand Court, with the plan expected to take effect on December 5, 2025 [19] - HashKey Holdings has passed the listing hearing with plans to raise $500 million and seek a listing this month [16] - The real estate crisis in China continues, with major data providers instructed to halt the release of sales data for property companies [17] Economic Indicators - China's official manufacturing PMI for November recorded at 49.2, below market expectations of 49.3 [13] - The non-manufacturing PMI for November was reported at 49.5, also below expectations of 50 [10] - Hong Kong's retail sales value for October increased by 6.9% year-on-year, with online sales rising over 27% [15]

中央金融工作会议将科技金融置于"五篇大文章"首位，明确了金融赋能科技创新的导向。在金融科 技蓬勃发展、科技创新引领未来的时代浪潮中，银行理财正以创新为笔、专业为墨，书写着支持科技创 新的精彩篇章。 一是以创新产品打通资金传导通道。2021年7月，我们设立科创投资部专注耕耘科创股权投资领 域，创新推出"金钻创投"系列私募理财产品，通过封闭式运作募集资金，投向私募股权基金来精准对接 和支持未上市科技企业，打通了理财资金与科创企业之间的"任督二脉"，将社会闲散资金高效汇聚，进 而转化为支持科技创新的长期稳定资本，有效填补了科创企业融资链条中的关键缺口。 二是构建"募投管退"的全流程管理机制。10年以来，杭银理财积累了长期的科创股权投资专业经验 和坚实的客户基础，形成了一套完善的"募投管退"全流程管理机制。 三是构建专业能力，高效稳健创造价值。在组织架构上，特设科创投资部，汇聚精通股权投资、行 业研究、风险管理等多领域的专业人才，形成高效协同的作战团队。同时组建10余人行业研究团队，聚 焦生物医药、商业航天、高端装备、信息技术等重点科创领域开展深度研究。 《金融时报》记者：在这套服务体系支撑下，杭银理财在支持科技创新 ...

Core Insights - A total of 15 stocks on the Sci-Tech Innovation Board experienced block trading on December 1, with a cumulative transaction amount of 360 million yuan [1][2]. Group 1: Trading Overview - There were 41 block trades executed, with a total trading volume of 10.18 million shares [1]. - The stock with the highest transaction amount was Guobo Electronics, which had 6 block trades totaling 7.306 million yuan [1]. - Other notable stocks in terms of transaction amounts included Haitai New Light and Lianyun Technology, with 4.872 million yuan and 3.81983 million yuan respectively [1]. Group 2: Price and Discount Analysis - All stocks involved in block trading were sold at a discount, with the highest discount rates observed in Sanyou Medical, Delong Laser, and Puyuan Information, at 16.46%, 12.68%, and 11.99% respectively [1][2]. - The average decline for stocks that underwent block trading was 0.46%, while the Sci-Tech 50 Index rose by 0.72% [1]. Group 3: Institutional Participation - Institutional transactions accounted for 18 trades involving 5 stocks, with Guobo Electronics leading in institutional buy amounts at 68.9976 million yuan [2]. - The stocks with the highest net inflow of funds included Hush Silicon Industry, Aerospace Software, and Haitai New Light, with net inflows of 20.4385 million yuan, 18.4593 million yuan, and 2.7452 million yuan respectively [2]. Group 4: Detailed Trading Data - A detailed table of block trading data includes various stocks, their transaction counts, volumes, average transaction prices, discount rates relative to closing prices, and total transaction amounts [3].

新华社柏林12月1日电 题：德企的选择，是中欧合作共赢生动写照 新华社记者李函林 大众集团近日在合肥启用全流程研发测试中心，首次实现在德国总部以外的新车平台"从概念到上 市"全链条开发，使整车研发周期缩短约三成，助力其更快响应全球最具活力汽车市场的需求。将核心 研发链条落地中国，不仅为顺应市场，更体现出对中国技术优势和产业生态的高度认可。 最新统计数据进一步印证了中德合作的韧性与潜力。2025年前9个月，中德双边贸易总额达1859亿 欧元，同比增长0.6％，中国再次成为德国最大贸易伙伴。双方贸易规模的稳步增长，凸显中德经贸互 补性：德国以工程技术和工业基础闻名，而中国企业以研发速度和技术进步著称，优势互补为企业开辟 了广阔发展空间。 在全球产业格局深刻调整、地缘竞争不断加剧的当下，德国企业持续加码中国市场，以务实行动为 中欧合作写下坚实注脚。尽管政治杂音和"去风险"叙事时有起伏，但德企以投资和研发布局中国的脚步 表明：以经济效益与技术创新为核心的理性判断，仍主导着企业的全球决策，而优势互补与互利共赢依 旧是中欧合作的稳固底色。 与此同时，中国企业也在德国稳步推进投资。德国联邦外贸与投资署数据显示，2024年， ...

Suspension and Resumption - Tailong Pharmaceutical's controlling shareholder is planning to transfer company shares, resulting in a stock suspension [1] Mergers and Acquisitions - Tanshan intends to acquire 51% equity of Shanghai Tongtu Semiconductor for 357 million yuan, with the target company engaged in IP technology licensing and chip design [2] Share Buybacks - Hengyi Petrochemical's controlling shareholder and its concerted parties plan to increase their holdings in the company by 1.5 billion to 2.5 billion yuan, with loans not exceeding 2 billion yuan [3] - Yongtai Energy plans to use 300 million to 500 million yuan for share buybacks aimed at cancellation [3] Investment Cooperation and Operational Status - Wolong New Energy is investing 804 million yuan to construct a 200,000 kW/1.2 million kWh independent energy storage demonstration project in Baotou [4] - Zhongchao Holdings' subsidiary won projects totaling 1.318 billion yuan, accounting for 23.97% of the company's audited revenue for 2024 [4] - Lizhong Group signed a technical agreement for commissioned processing of humanoid robot components with Weijing Intelligent [4] - Kaiwang Technology plans to establish a liquid cooling subsidiary with Wenjian Technology [4] - Ruishun Technology received a notice for a 331 million yuan cotton picker spindle production equipment construction project [4] - Tongyu Communication is accelerating its 6G research and low-orbit satellite internet layout [4] - Samsung Medical's subsidiary signed a contract for an annual bidding project for electric meters in Indonesia, with a contract value of approximately 160 million yuan [4] - Top Group is planning to issue H-shares and list on the Hong Kong Stock Exchange [4]

格隆汇12月1日丨三星医疗(601567.SH)公布，公司下属全资子公司PTCITRASANXING INDONESIA （简称"印尼三星"）签订印尼电表年度招标项目合同，合同金额总计3,751.66亿印尼盾，约合1.60亿人 民币。 ...

来源：新浪证券-红岸工作室 12月1日，海泰新光涨2.02%，成交额7575.18万元，换手率1.40%，总市值54.47亿元。 异动分析 医疗器械概念+人民币贬值受益+专精特新 1、公司始终致力于将光学技术与医疗器械行业的前沿应用趋势相结合，研究发展高性能的尖端内窥镜 器械产品。目前，公司是国内少有的具备从核心部件、关键设备到系统集成的行业垂直整合能力的企 业。 2、根据2024年年报，公司海外营收占比为69.12%，受益于人民币贬值。 3、专精特新"小巨人"企业是全国中小企业评定工作中最高等级、最具权威的荣誉称号，是指专注于细 分市场、创新能力强、市场占有率高、掌握关键核心技术、质量效益优的排头兵企业，对于提升中小企 业自身的竞争力，以及提升产业链、供应链稳定性和竞争力具有重大意义。公司已入选工信部专精特新 小巨人企业名单。 (免责声明：分析内容来源于互联网，不构成投资建议，请投资者根据不同行情独立判断) 区间今日近3日近5日近10日近20日主力净流入162.78万-1212.84万-1768.35万-3339.43万-3432.76万 主力持仓 主力轻度控盘，筹码分布较为分散，主力成交额2093.91万 ...

12月1日，山外山盘中下跌2.02%，截至14:29，报15.00元/股，成交5400.13万元，换手率1.53%，总市值 47.94亿元。 资金流向方面，主力资金净流出180.60万元，特大单买入0.00元，占比0.00%，卖出233.02万元，占比 4.32%；大单买入568.04万元，占比10.52%，卖出515.61万元，占比9.55%。 分红方面，山外山A股上市后累计派现1.04亿元。 机构持仓方面，截止2025年9月30日，山外山十大流通股东中，鹏华医药科技股票A（001230）位居第 四大流通股东，持股518.20万股，为新进股东。博时医疗保健混合A（050026）位居第六大流通股东， 持股325.70万股，持股数量较上期不变。 责任编辑：小浪快报 资料显示，重庆山外山血液净化技术股份有限公司位于重庆市两江新区慈济路1号，成立日期2001年3月 26日，上市日期2022年12月26日，公司主营业务涉及血液净化设备的研发、生产和销售。主营业务收入 构成为：血液净化设备66.12%，血液净化耗材23.89%，医疗服务8.31%，其他1.68%。 山外山所属申万行业为：医药生物-医疗器械-医疗设备。所 ...